Stock SHL SONIC HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sonic Healthcare Limited

Equities

SHL

AU000000SHL7

Healthcare Facilities & Services

Market Closed - Australian S.E.
Other stock markets
 02:10:44 2024-04-26 am EDT 		5-day change 1st Jan Change
26.34 AUD -1.50% Intraday chart for Sonic Healthcare Limited +0.27% -17.89%
Apr. 23 Microba's Revenue Climbs 297% in Fiscal Q3 MT
Mar. 20 Sonic Healthcare Limited agreed to acquire Dr. Risch Shared Services Ag for CHF 117 million. CI

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 12,844 14,460 18,352 15,573 16,747 12,654 - -
Enterprise Value (EV) 1 15,143 17,845 20,687 16,370 19,049 15,254 15,172 14,968
P/E ratio 22.2 x 27.5 x 14.1 x 10.9 x 24.5 x 22.8 x 18.3 x 16.3 x
Yield 3.1% 2.79% 2.37% 3.03% 2.92% 3.8% 4.06% 4.33%
Capitalization / Revenue 2.09 x 2.12 x 2.1 x 1.67 x 2.05 x 1.44 x 1.35 x 1.3 x
EV / Revenue 2.47 x 2.61 x 2.36 x 1.75 x 2.33 x 1.73 x 1.62 x 1.54 x
EV / EBITDA 14.3 x 12.5 x 8.08 x 5.78 x 11.2 x 9.1 x 8.01 x 7.39 x
EV / FCF 26.8 x 15.9 x 11.7 x 8.44 x 17.6 x 20.2 x 15.3 x 14 x
FCF Yield 3.74% 6.31% 8.55% 11.8% 5.68% 4.95% 6.53% 7.15%
Price to Book 2.37 x 2.55 x 2.87 x 2.14 x 2.17 x 1.59 x 1.56 x 1.52 x
Nbr of stocks (in thousands) 473,945 475,174 477,907 471,771 470,806 480,404 - -
Reference price 2 27.10 30.43 38.40 33.01 35.57 26.34 26.34 26.34
Announcement Date 8/19/19 8/19/20 8/23/21 8/23/22 8/16/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 6,134 6,832 8,752 9,340 8,169 8,816 9,344 9,722
EBITDA 1 1,061 1,425 2,560 2,830 1,708 1,676 1,895 2,026
EBIT 1 787.7 819.2 1,918 2,155 1,005 906.7 1,097 1,208
Operating Margin 12.84% 11.99% 21.92% 23.07% 12.3% 10.28% 11.74% 12.42%
Earnings before Tax (EBT) 1 722.3 699.1 1,829 2,077 931.2 784.9 963.1 1,093
Net income 1 549.7 527.7 1,315 1,461 685 551.3 690.4 776.4
Net margin 8.96% 7.72% 15.03% 15.64% 8.39% 6.25% 7.39% 7.99%
EPS 2 1.221 1.106 2.731 3.025 1.450 1.154 1.441 1.617
Free Cash Flow 1 565.7 1,125 1,769 1,939 1,082 755.4 990.3 1,070
FCF margin 9.22% 16.47% 20.22% 20.76% 13.24% 8.57% 10.6% 11.01%
FCF Conversion (EBITDA) 53.33% 78.97% 69.12% 68.5% 63.36% 45.07% 52.27% 52.8%
FCF Conversion (Net income) 102.91% 213.24% 134.54% 132.75% 157.95% 137.02% 143.43% 137.81%
Dividend per Share 2 0.8400 0.8500 0.9100 1.000 1.040 0.9998 1.070 1.142
Announcement Date 8/19/19 8/19/20 8/23/21 8/23/22 8/16/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: Juni 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 3,344 3,488 4,432 4,319 4,757 4,584 4,082 4,087 4,306 4,613 4,613 4,857
EBITDA 1 548 877.1 1,307 1,253 1,540 1,291 920.2 787.3 736.7 965 960 1,030
EBIT 1 399.9 419.3 993.8 924.4 1,208 947 574.6 430 353 560 551 605
Operating Margin 11.96% 12.02% 22.42% 21.4% 25.39% 20.66% 14.07% 10.52% 8.2% 12.14% 11.94% 12.46%
Earnings before Tax (EBT) 1 347.4 - 944 884.6 1,168 908.7 536.9 394.3 300 488 479 539
Net income 1 256 271.7 677.6 637.4 827.7 632.9 382.4 302.6 202.3 342 323 378
Net margin 7.66% 7.79% 15.29% 14.76% 17.4% 13.81% 9.37% 7.41% 4.7% 7.41% 7% 7.78%
EPS 2 0.5370 0.5690 1.409 1.322 1.708 1.317 0.8090 0.6410 0.4260 0.7280 0.6425 0.7305
Dividend per Share 2 0.3400 0.5100 0.3600 0.5500 0.4000 0.6000 0.4200 0.6200 0.4300 0.6510 0.4520 0.7300
Announcement Date 2/18/20 8/19/20 2/17/21 8/23/21 2/20/22 8/23/22 2/15/23 8/16/23 2/19/24 - - -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: Juni 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 2,299 3,386 2,335 797 2,302 2,600 2,518 2,314
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.167 x 2.376 x 0.9122 x 0.2816 x 1.348 x 1.551 x 1.329 x 1.142 x
Free Cash Flow 1 566 1,125 1,769 1,939 1,082 755 990 1,070
ROE (net income / shareholders' equity) 11.5% 9.46% 22% 21.4% 9.05% 6.96% 8.51% 9.4%
ROA (Net income/ Total Assets) 6.05% 4.78% 11% 12% 5.36% 4.37% 5.17% 5.67%
Assets 1 9,080 11,044 11,944 12,156 12,776 12,604 13,362 13,701
Book Value Per Share 2 11.40 11.90 13.40 15.40 16.40 16.60 16.80 17.30
Cash Flow per Share 2 1.880 2.850 4.240 4.610 3.110 2.520 2.930 3.130
Capex 1 282 235 274 287 389 501 515 545
Capex / Sales 4.59% 3.44% 3.13% 3.07% 4.76% 5.68% 5.51% 5.6%
Announcement Date 8/19/19 8/19/20 8/23/21 8/23/22 8/16/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Sonic Healthcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
26.34 AUD
Average target price
30.69 AUD
Spread / Average Target
+16.53%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.57B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
ADICON HOLDINGS LIMITED Stock Adicon Holdings Limited
-15.34% 1.03B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. SHL Stock
  4. Financials Sonic Healthcare Limited